TREM2 INHIBITION REPROGRAMS MYELOID CELLS TO STIMULATE ANTI-TUMOR IMMUNITY THROUGH BOTH DIRECT AND INDIRECT MECHANISMS

被引:0
|
作者
Sun, Rui [1 ]
Han, Rowland [1 ]
McCornack, Colin [1 ]
Tabor, G. Travis [1 ]
Hou, Jinchao [1 ]
Cleary, Ryan [1 ]
Mao, Diane [1 ]
Liu, Qin [1 ]
Schoch, Kathleen [1 ]
Luo, Jingqin [1 ]
Petti, Allegra [2 ]
Miller, TImothy [1 ]
Ulrich, Jason [1 ]
Holtzman, David [1 ]
Kim, Albert [1 ]
机构
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Mass Gen Hosp, Boston, MA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IMMU-28
引用
收藏
页数:1
相关论文
共 50 条
  • [31] FcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity
    Vijayashree Mysore
    Xavier Cullere
    Joseph Mears
    Florencia Rosetti
    Koshu Okubo
    Pei X. Liew
    Fan Zhang
    Iris Madera-Salcedo
    Frank Rosenbauer
    Richard M. Stone
    Jon C. Aster
    Ulrich H. von Andrian
    Andrew H. Lichtman
    Soumya Raychaudhuri
    Tanya N. Mayadas
    Nature Communications, 12
  • [32] DETECTION OF ANTI-TUMOR IMMUNITY IN MAN BY THE INDIRECT MACROPHAGE ADHERENCE INHIBITION ASSAY USING GUINEA-PIG PERITONEAL-CELLS AS INDICATOR CELLS
    SCHIMKE, R
    AMBROSIUS, H
    NEOPLASMA, 1981, 28 (01) : 103 - 110
  • [33] Tozasertib activates anti-tumor immunity through decreasing regulatory T cells in melanoma
    Wang, Qiaoling
    Liu, Wuyi
    Zhou, Huyue
    Lai, Wenjing
    Hu, Changpeng
    Dai, Yue
    Li, Guobing
    Zhang, Rong
    Zhao, Yu
    NEOPLASIA, 2024, 48
  • [34] The anti-tumor effects of interleukin-12 occur through distinct mechanisms in different tumor models: Immunity vs. angiogenesis-inhibition.
    Moran, JP
    Frelinger, JG
    Lord, EM
    FASEB JOURNAL, 2000, 14 (06): : A1010 - A1010
  • [35] Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell Carcinoma
    Ford, Jill W.
    Gonzalez-Cotto, Marieli
    MacFarlane, Alexander W.
    Peri, Suraj
    Howard, O. M. Zack
    Subleski, Jeffrey J.
    Ruth, Karen J.
    Haseebuddin, Mohammed
    Al-Saleem, Tahseen
    Yang, Youfeng
    Rayman, Pat
    Rini, Brian
    Linehan, W. Marston
    Finke, James
    Weiss, Jonathan M.
    Campbell, Kerry S.
    McVicar, Daniel W.
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [36] Anti-liver fibrotic effect of triggering receptor expressed on myeloid cells 2 (TREM2) via macrophage phenotype switching
    Kang, Byeongseok
    Kim, Nayoun
    Yang, Jin Won
    Kang, Keon Wook
    FASEB JOURNAL, 2018, 32 (01):
  • [37] Combined CDK and BET inhibition reprograms the tumor and stromal compartments to enhance anti-tumor immunity in immunologically-cold CDKN2A-deficient pancreatic cancer.
    Olson, Brian M.
    Thomas, Alison J.
    Ware, Michael B.
    Lesinski, Gregory B.
    CANCER RESEARCH, 2021, 81 (22) : 83 - 84
  • [38] TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma (vol 9, eade3559, 2023)
    Sun
    SCIENCE ADVANCES, 2024, 10 (21):
  • [39] Inhibition of A20 expression in tumor microenvironment exerts anti-tumor effect through inducing myeloid-derived suppressor cells apoptosis
    Bin Shao
    Xiawei Wei
    Min Luo
    Jiayun Yu
    Aiping Tong
    Xuelei Ma
    Tinghong Ye
    Hongxin Deng
    Yaxiong Sang
    Xiao Liang
    Yu Ma
    Qinjie Wu
    Wei Du
    Jing Du
    Xiang Gao
    Yi Wen
    Ping Fu
    Huashan Shi
    Shuntao Luo
    Yuquan Wei
    Scientific Reports, 5
  • [40] Inhibition of A20 expression in tumor microenvironment exerts anti-tumor effect through inducing myeloid-derived suppressor cells apoptosis
    Shao, Bin
    Wei, Xiawei
    Luo, Min
    Yu, Jiayun
    Tong, Aiping
    Ma, Xuelei
    Ye, Tinghong
    Deng, Hongxin
    Sang, Yaxiong
    Liang, Xiao
    Ma, Yu
    Wu, Qinjie
    Du, Wei
    Du, Jing
    Gao, Xiang
    Wen, Yi
    Fu, Ping
    Shi, Huashan
    Luo, Shuntao
    Wei, Yuquan
    SCIENTIFIC REPORTS, 2015, 5